ATE384524T1 - Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis - Google Patents

Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis

Info

Publication number
ATE384524T1
ATE384524T1 AT00946319T AT00946319T ATE384524T1 AT E384524 T1 ATE384524 T1 AT E384524T1 AT 00946319 T AT00946319 T AT 00946319T AT 00946319 T AT00946319 T AT 00946319T AT E384524 T1 ATE384524 T1 AT E384524T1
Authority
AT
Austria
Prior art keywords
nitroimidazole
group
preparations
treatment
atopic dermatitis
Prior art date
Application number
AT00946319T
Other languages
English (en)
Inventor
Nishizumi Nishimuta
Kazuhiro Nishimuta
Original Assignee
Shoei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shoei Co Ltd filed Critical Shoei Co Ltd
Application granted granted Critical
Publication of ATE384524T1 publication Critical patent/ATE384524T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
AT00946319T 1999-07-16 2000-07-14 Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis ATE384524T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP23449699 1999-07-16
JP11206508 1999-07-21
JP11271077 1999-09-24
JP31284099 1999-09-28
JP2000042012 2000-01-14
JP2000067746 2000-02-04

Publications (1)

Publication Number Publication Date
ATE384524T1 true ATE384524T1 (de) 2008-02-15

Family

ID=27553827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946319T ATE384524T1 (de) 1999-07-16 2000-07-14 Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis

Country Status (10)

Country Link
US (1) US20030092754A1 (de)
EP (1) EP1206937B1 (de)
KR (1) KR100671879B1 (de)
CN (1) CN1304001C (de)
AT (1) ATE384524T1 (de)
AU (1) AU773881B2 (de)
CA (1) CA2379270C (de)
DE (1) DE60037892T2 (de)
HK (1) HK1046639B (de)
WO (1) WO2001005400A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030206965A1 (en) * 2000-09-29 2003-11-06 The Procter & Gamble Company Allergen neutralization compositions
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US7658941B2 (en) 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7417013B2 (en) 2002-05-01 2008-08-26 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
KR20050025166A (ko) * 2002-05-01 2005-03-11 맥네일-피피씨, 인코포레이티드 가온성 및 무자극성 윤활제 항진균성 겔 조성물
US20040167039A1 (en) * 2002-05-01 2004-08-26 Nawaz Ahmad Warming and nonirritating lubricant compositions and method of comparing irritation
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US20040185065A1 (en) * 2002-05-01 2004-09-23 Nawaz Ahmad Warming and nonirritating lubricant compositions and method of comparing irritation
US7695730B2 (en) 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US20030215397A1 (en) * 2002-05-14 2003-11-20 Noah Patricia W. Method of treatment of skin diseases related to microbial antigens in the skin
CA2496864C (en) 2002-08-26 2009-04-28 S.L.A. Pharma Ag A pharmaceutical composition
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US7238212B2 (en) * 2003-06-02 2007-07-03 L'oreal, S.A. Imidazole compounds and use of these compounds for dyeing keratinous fibers
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
US20060040002A1 (en) * 2004-08-17 2006-02-23 Boitano Suzanne M Anti-itch composition
US20070237809A1 (en) * 2004-08-30 2007-10-11 Phaneuf Matthew D Multi-functional bioactive wound dressing
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US7851419B2 (en) 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
US7320801B2 (en) * 2005-09-26 2008-01-22 Jack Perez Kelly Patch for treating symptoms of a skin abscess
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US20070179121A1 (en) * 2006-02-02 2007-08-02 Plott R T Method of treating pediatric patients with corticosteroids
FR2899475A1 (fr) * 2006-04-10 2007-10-12 Galderma Res & Dev Composition pharmaceutique pour le traitement de la rosacee
US20080063668A1 (en) * 2006-09-12 2008-03-13 Borgman Robert J Nitroimidazole and terconazole composition and method
FR2909876A1 (fr) * 2006-12-19 2008-06-20 Galderma Res & Dev S N C Snc Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques
US7758901B2 (en) * 2007-02-16 2010-07-20 Betty Bellman Compositions and methods for alleviating skin disorders
US7488500B2 (en) * 2007-02-16 2009-02-10 Betty Bellman Compositions and methods for alleviating skin disorders
US9011943B2 (en) * 2007-02-16 2015-04-21 Skin Evolution LLC Compositions and methods for alleviating skin disorders
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
IT1396731B1 (it) * 2009-11-25 2012-12-14 Masci Composizione farmaceutica a base di metronidazolo ed ossido di zinco per il trattamento topico di patologie anali acute e croniche distrofiche e post-operatorie
AU2015244700B2 (en) 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
CN104147044B (zh) * 2014-08-28 2017-02-22 湖南农业大学 一种治疗仔猪葡萄球菌性渗出性皮炎的组合物
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
CN106580978A (zh) * 2016-11-30 2017-04-26 郑州仁宏医药科技有限公司 一种治疗皮炎的西药组合物及其应用
TWI820142B (zh) 2018-05-29 2023-11-01 日商大塚製藥工場股份有限公司 外用組成物
CN108503589B (zh) * 2018-06-20 2021-05-14 徐州工业职业技术学院 一种硝酸益康唑的制备方法
US20220288038A1 (en) * 2019-08-21 2022-09-15 The University Of Tokyo Abcc11 inhibitor
CN110773086B (zh) * 2019-11-20 2025-05-13 黄冈银河阿迪药业有限公司 模拟临界状态雾化流羟化合成甲硝唑的装置及其合成方法
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
CN112138015B (zh) * 2020-10-22 2022-08-05 合肥博思科创医药科技有限公司 三苄糖苷在治疗微循环障碍引起的皮肤疾病中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491588A (en) * 1982-03-31 1985-01-01 University Of Tennessee Research Corporation Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4957918A (en) * 1988-06-09 1990-09-18 Leonard Bloom Topical treatment of blepharitis
CN1068038A (zh) * 1991-06-27 1993-01-20 杨昌道 足癣膏的配方及制作方法
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
RU2080864C1 (ru) * 1993-11-09 1997-06-10 Евгений Владимирович Намоконов Средство для лечения гнойных ран
JPH07179341A (ja) * 1993-12-22 1995-07-18 Toko Yakuhin Kogyo Kk 安定なミコフェノール酸含有皮膚外用剤
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
CN1137890A (zh) * 1995-06-10 1996-12-18 董闽安 一种消除痤疮及其沉积色素的美容品青春霜和加工方法
CA2161737C (en) * 1995-10-30 1998-10-20 Richard J. Mackay Metronidazole gel
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US6482839B1 (en) * 1997-06-02 2002-11-19 Cellegy Pharmaceuticals, Inc. Pyridine-thiols for treatment of a follicular dermatosis
AU8588898A (en) * 1997-07-28 1999-02-16 Mary L. Redmond Composition and process for the treatment of epidermal traumas such as decubitusulcers
EP0995781B1 (de) * 1998-04-23 2004-08-18 Idemitsu Petrochemical Co., Ltd. Beschichtungszusammensetzung
CN1090936C (zh) * 1999-05-19 2002-09-18 张广政 一种治疗痤疮的复合制剂

Also Published As

Publication number Publication date
CN1304001C (zh) 2007-03-14
WO2001005400A1 (en) 2001-01-25
KR20020020780A (ko) 2002-03-15
HK1046639B (zh) 2007-10-05
CN1361688A (zh) 2002-07-31
KR100671879B1 (ko) 2007-01-19
HK1046639A1 (en) 2003-01-24
US20030092754A1 (en) 2003-05-15
DE60037892T2 (de) 2009-01-15
AU6016100A (en) 2001-02-05
AU773881B2 (en) 2004-06-10
EP1206937A4 (de) 2005-01-19
EP1206937B1 (de) 2008-01-23
CA2379270A1 (en) 2001-01-25
CA2379270C (en) 2007-04-10
DE60037892D1 (de) 2008-03-13
EP1206937A1 (de) 2002-05-22

Similar Documents

Publication Publication Date Title
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
BR0215052A (pt) Composições acaricidas e métodos
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
BR0207025A (pt) Derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
DE59600105D1 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Tinnitus
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
GEP20032913B (en) Thienylazolylalcoxyethanamines, Their Preparation and Their Application as Medicaments
DE69221251D1 (de) Fungizides Mittel, seine Herstellung und Mikroorganismus dafür
ATE223718T1 (de) Verwendung von riminophenazin zur behandlung von mdr-resistenz
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
HK1046404A1 (zh) 用作nmda受体拮抗剂的取代的吡咯烷-2，3，4-三酮-3-肟衍生物
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
YU33202A (sh) Jedinjenja o-etar oksima i fungicidi za primenu u zemljoradnji i vrtlarstvu
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE266027T1 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
DE69518159D1 (de) Mittel zur vorsorge und heilung von typ i allergischen krankheiten
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
DE69822636D1 (de) Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe
DE69708484D1 (de) Pyridinderivate,als Arzneimittel zur Behandlung von Geschwüren und als antibakterielle Mittel
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206937

Country of ref document: EP